Home/Filings/4/0001042167-16-000291
4//SEC Filing

FEMALE HEALTH CO 4

Accession 0001042167-16-000291

$VERUCIK 0000863894operating

Filed

Nov 1, 8:00 PM ET

Accepted

Nov 2, 1:46 PM ET

Size

16.1 KB

Accession

0001042167-16-000291

Insider Transaction Report

Form 4
Period: 2016-10-31
Transactions
  • Award

    Common Stock, par value $.01 per share

    2016-10-31+140,000389,115 total
  • Exercise/Conversion

    Common Stock, par value $.01 per share

    2016-10-31+16,667405,782 total
  • Award

    Common Stock Option

    2016-10-31$0.95/sh+140,000$133,000140,000 total
    Exercise: $0.95From: 2017-10-31Exp: 2026-10-31Common Stock (140,000 underlying)
  • Award

    Restricted Stock Units

    2016-10-31+140,000280,000 total
    From: 2018-10-31Exp: 2018-10-31Common Stock (140,000 underlying)
  • Award

    Stock Appreciation Rights

    2016-10-31+140,000420,000 total
    Exercise: $0.95From: 2018-10-31Exp: 2026-10-31Common Stock (140,000 underlying)
  • Exercise/Conversion

    Right to Receive Common Stock

    2016-10-31+16,6670 total
    From: 2016-10-31Exp: 2016-10-31Common Stock (16,667 underlying)
Footnotes (3)
  • [F1]The reporting person had the right to receive at his election either 16,667 shares of FHCO common stock or cash based on the market value of 16,667 shares of FHCO common stock as of October 31, 2016, which was $0.95 per share. The reporting person elected to receive 16,667 shares of FHCO common stock.
  • [F2]The reporting person has the right to receive 140,000 shares of FHCO common stock if, prior to the second anniversary of the date of grant, FHCO receives shareholder approval under NASDAQ Rule 5635(c) to (i) increase the number of authorized shares under the 2008 Stock Incentive Plan sufficient to issue such shares or (ii) adopt a new plan under which such shares would be issued. If such approval is not received by such date, such awards will be settled in cash based on the fair market value of FHCO common stock on the vesting date.
  • [F3]The stock appreciation rights will be settled in stock if, prior to the second anniversary of the date of grant, FHCO receives shareholder approval under NASDAQ Rule 5635(c) to (i) increase the number of authorized shares under the 2008 Stock Incentive Plan sufficient to issue such shares or (ii) adopt a new plan under which such shares would be issued. If such approval is not received by such date, such rights will be settled in cash based on the fair market value of FHCO common stock on the exercise date.

Issuer

FEMALE HEALTH CO

CIK 0000863894

Entity typeoperating
IncorporatedWI

Related Parties

1
  • filerCIK 0000863894

Filing Metadata

Form type
4
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 1:46 PM ET
Size
16.1 KB